Ventana costs mount in Roche fight
Nov. 12 - Ventana Medical System's CEO says "the costs associated with the hostile environment Roche has placed us in are significant."
Christopher Gleeson, speaking at the Reuters Health Summit in New York on Monday, says, "We've made it pretty clear that $75 is a non-starter...we've also made it clear that if Roche were to indicate that they also see that value...we'd be happy to talk to them." SPEAKER: Christopher Gleeson CEO, Ventana Medical Systems
No videos currently selected.
Click 
on any video below, from any channel, to add it to your playlist.
Senate healthcare debate begins
Featured Videos
Reuters.com:
Help and Contact Us |
Advertise With Us |
Mobile |
Newsletters |
RSS
|
Labs |
Journalism Handbook |
Archive |
Site Index |
Video Index
Thomson Reuters Corporate: Copyright | Disclaimer | Privacy | Professional Products | Professional Products Support | About Thomson Reuters | Careers
International Editions: Africa | Arabic | Argentina | Brazil | Canada | China | France | Germany | India | Italy | Japan | Latin America | Mexico | Russia | Spain | United Kingdom | United States
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
